GUTS
Income statement / Annual
Last year (2024), Fractyl Health, Inc. Common Stock's total revenue was $93.00 K,
a decrease of 22.50% from the previous year.
In 2024, Fractyl Health, Inc. Common Stock's net income was -$68.69 M.
See Fractyl Health, Inc. Common Stock,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$93.00 K |
$120.00 K |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$50.00 K
|
$77.00 K
|
$452.00 K
|
$0.00
|
$770.00 K
|
$893.00 K
|
| Gross Profit |
$43.00 K
|
$43.00 K
|
-$452.00 K
|
$0.00
|
-$770.00 K
|
-$893.00 K
|
| Gross Profit Ratio |
0.46
|
0.36
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$70.47 M
|
$38.04 M
|
$34.35 M
|
$26.44 M
|
$22.43 M
|
$20.89 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$15.03 M
|
$10.49 M
|
$6.53 M
|
$9.03 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
-$452.00 K
|
$0.00
|
-$770.00 K
|
-$893.00 K
|
| Selling, General & Administrative Expenses |
$0.00
|
$0.00
|
$14.58 M
|
$10.49 M
|
$5.76 M
|
$8.14 M
|
| Other Expenses |
$23.10 M
|
$12.84 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$93.57 M
|
$50.88 M
|
$48.93 M
|
$36.93 M
|
$28.19 M
|
$29.03 M
|
| Cost And Expenses |
$93.62 M
|
$50.96 M
|
$49.39 M
|
$36.93 M
|
$28.96 M
|
$29.92 M
|
| Interest Income |
$4.15 M
|
$1.26 M
|
$797.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$1.44 M
|
$1.50 M
|
$635.00 K
|
| Depreciation & Amortization |
$677.00 K
|
$286.00 K
|
$452.00 K
|
$676.00 K
|
$770.00 K
|
$893.00 K
|
| EBITDA |
-$92.85 M |
-$50.55 M |
-$48.93 M |
-$36.25 M |
-$28.19 M |
-$29.03 M |
| EBITDA Ratio |
-998.43
|
-421.25
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-1005.71
|
-423.63
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$24.84 M
|
-$26.26 M
|
$2.93 M
|
-$1.81 M
|
-$1.52 M
|
-$673.00 K
|
| Income Before Tax |
-$68.69 M
|
-$77.09 M
|
-$46.45 M
|
-$38.74 M
|
-$30.48 M
|
-$30.59 M
|
| Income Before Tax Ratio |
-738.65
|
-642.43
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$68.69 M
|
-$77.09 M
|
-$46.45 M
|
-$38.74 M
|
-$30.48 M
|
-$30.59 M
|
| Net Income Ratio |
-738.65
|
-642.43
|
0
|
0
|
0
|
0
|
| EPS |
-1.62 |
-1.98 |
-1.34 |
-1.12 |
-0.86 |
-0.64 |
| EPS Diluted |
-1.62 |
-1.98 |
-1.34 |
-1.12 |
-0.86 |
-0.64 |
| Weighted Average Shares Out |
$43.54 M
|
$47.61 M
|
$47.61 M
|
$47.61 M
|
$47.61 M
|
$47.61 M
|
| Weighted Average Shares Out Diluted |
$43.54 M
|
$47.61 M
|
$47.61 M
|
$47.61 M
|
$47.61 M
|
$47.61 M
|
| Link |
|
|
|
|
|
|
